Cardinal Health (CAH)
(Delayed Data from NYSE)
$96.39 USD
+0.34 (0.35%)
Updated May 24, 2024 04:00 PM ET
After-Market: $96.40 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
CAH 96.39 +0.34(0.35%)
Will CAH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CAH
Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
Other News for CAH
Cardinal Health's Valuation Makes The Name Unattractive
UnitedHealth's OptumRx Unveils New Transparent Drug Pricing Initiative for 2024
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
Larry Robbins' Glenview Capital takes in Broadcom, exits Intel among Q1 moves
Cardinal Health, Inc. (CAH) Presents at BofA Securities 2024 Health Care Conference (Transcript)